Cookies on the BTG website

We use cookies to ensure that we give you the best experience on our website.

If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the BTG website.

Find out more
Continue

About Us

Utilities
Print
Email
Email to a friend
Email to a friend

* Required

Strategy

We are focused on bringing to market medical products that meet the needs of specialist physicians and their patients, thereby building a leading specialist healthcare business that delivers superior returns to shareholders.

We aim to expand our portfolio of marketed products through acquisition, development and commercial activities.

We established commercial operations in late 2010 and now sell our Specialty Pharmaceutical, Interventional Oncology and Interventional Vascular products direct to customers in the US.

Outside of the US our strategy is to work with partners and distributors to register and sell our products. We will keep this under review and will consider direct sales in certain territories where the economics make sense and where we have the right capabilities. We are actively pursuing an international expansion strategy for our Interventional Oncology products, in particular in Asia where high infection rates of hepatitis B and C have led to a high incidence of liver cancer.

Our research and development focus is on products that we can commercialise ourselves. We are conducting a number of exploratory studies on our interventional bead products and plan to initiate regulatory studies designed to expand the indicated uses for these products.

Latest news
latest news

Read our latest news and find out about our recent achievements and company milestones.

Our path to success

Our rich heritage has helped us to become the successful company we are today.